News
EKSO
1.700
0.00%
0.000
Ekso Bionics Granted European Patent Titled 'EXOSKELETON AND METHOD OF INCREASING THE FLEXIBILITY OF AN EXOSKELETON HIP JOINT'
Benzinga · 12/09/2022 15:53
BRIEF-Ekso Bionics Announces Acquisition Of Human Motion, Control Business Unit Including Indego Product Line From Parker Hannifin Corp
Reuters · 12/05/2022 14:11
Ekso Bionics Announces Acquisition Of Human Motion and Control Business Unit Including Indego Product Line From Parker Hannifin Corporation For An Aggregate Purchase Price Of $10M
Benzinga · 12/05/2022 13:39
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/03/2022 22:05
Ekso Bionics Holdings GAAP EPS of -$0.33, revenue of $3.3M
Seekingalpha · 11/03/2022 20:28
Ekso Bionics Reports Third Quarter 2022 Results
Quarterly Record of 33 EksoNR Bookings in Q3 2022 SAN RAFAEL, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported ...
GlobeNewswire · 11/03/2022 20:05
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Reports Q3 Revenue $3.3M
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Reports Q3 Revenue $3.3M
MT Newswires · 11/03/2022 16:29
Preview: Ekso Bionics Holdings's Earnings
Benzinga · 11/02/2022 16:15
BRIEF-Ekso Bionics Holdings Inc Board Of Directors Approved Jerome Wong As Chief Financial Officer On Oct. 26
Reuters · 10/31/2022 10:39
Ekso Bionics Holdings, On October 26, 2022, Board Of Directors Approved Appointment Of Jerome Wong As Chief Financial Officer
Benzinga · 10/31/2022 10:11
Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Simply Wall St. · 09/11/2022 12:10
Ekso Bionics Holdings's Return On Capital Employed Insights
According to Benzinga Pro data, during Q2, Ekso Bionics Holdings (NASDAQ:EKSO) posted sales of $3.46 million. Earnings were up 35.54%, but Ekso Bionics Holdings still reported an overall loss of $2.98 million.
Benzinga · 08/05/2022 14:38
--HC Wainwright Adjusts Price Target on Ekso Bionics Holdings to $9 From $11, Reiterates Buy Rating
--HC Wainwright Adjusts Price Target on Ekso Bionics Holdings to $9 From $11, Reiterates Buy Rating
MT Newswires · 07/29/2022 09:06
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/28/2022 21:35
Ekso Bionics Holdings Q2 EPS $(0.23) Beats $(0.24) Estimate, Sales $3.50M Beat $3.49M Estimate
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 109.09 percent decrease over losses of $(0.11) per share
Benzinga · 07/28/2022 20:36
Ekso Bionics Holdings GAAP EPS of -$0.23 beats by $0.01, revenue of $3.5M beats by $0.01M
Ekso Bionics Holdings press release (NASDAQ:<a href="h...
Seekingalpha · 07/28/2022 20:22
Ekso Bionics Reports Second Quarter 2022 Results
RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30...
GlobeNewswire · 07/28/2022 20:05
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q2 Revenue $3.5M
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q2 Revenue $3.5M
MT Newswires · 07/28/2022 16:07
Ekso Bionics Holdings Earnings Preview
Ekso Bionics Holdings (NASDAQ:EKSO) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Ekso Bionics Holdings will report an earnings per share (EPS...
Benzinga · 07/27/2022 17:35
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results...
GlobeNewswire · 07/21/2022 12:00
More
Webull provides a variety of real-time EKSO stock news. You can receive the latest news about Ekso Bionics through multiple platforms. This information may help you make smarter investment decisions.
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.